Earlier last week, ServiceNow (NYSE:NOW) reported its second quarter results that soared past market expectations. The impressive performance and outlook sent the stock climbing 13% in the after-hours trading session.
Oracle (NYSE: ORCL) recently reported its fourth quarter results that missed estimates. But despite the weak results, the market was impressed given the strong Oracle Cloud Infrastructure (OCI) demand that it is seeing coming its way.
According to a market report, the use of AI in medical diagnostics is expected to grow at 25% CAGR from $0.8 billion in 2022. Chicago-based Tempus AI (Nasdaq: TEM) is a leading player in the market that recently went public to a weak market response.
The rapid rise of generative AI technology has led to a growing concern around safety and security around the development of the technology. Backed by both Google and Amazon, Anthropic PBC is a public benefit company (PBC) that is focused on ensuring that they build systems that people can rely on and generate research about
According to a recent report, the global robotic process automation (RPA) market is expected to grow at 40% CAGR from $2.94 billion in 2023. San Francisco-based Automation Anywhere is another high growth AI unicorn that is experiencing a similar meteoric growth.
According to a recent report, the global AI market is estimated to grow at 36% CAGR from $214.6 billion in 2024 to $1.339 trillion by 2030. This has accelerated the growth of companies like Scale AI that are providing resources for development of AI solutions.
Digital signature services provider Docusign (Nasdaq: DOCU) recently announced strong quarterly results. The company is looking to expand its market reach through a focused AI-based strategy for document management.
The global healthcare cloud computing market is expected to grow 18% annually to reach $320.9 billion by 2034 from $41.1 billion in 2024. The growth in the market is estimated to be driven by the increasing adoption of AI and data analytics in the industry along with the expansion of telehealth and remote monitoring capabilities. Veeva